Cancer
Test for ovarian, endometrial cancers
Could cells taken from a Pap test offer the first-ever early screening method?
Every year, nearly 70,000 women in the United States are diagnosed with ovarian and endometrial cancers, and about one-third of them die. Researchers at Johns Hopkins University have developed a test they say can detect ovarian and endometrial cancers from fluid taken during a routine Pap test. The new test—called PapGene—analyzes DNA from ovarian and endometrial cancer cells that have been shed into the cervical fluid.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.